Melanoma is a highly aggressive skin cancer with a limited targeted therapy arsenal. Ruthenium-based complexes have shown interesting pro-apoptotic effects on malignant tumor cell lines. In this study three ruthenium(II) complexes containing cinnamic acid derivatives as ligands were synthesized and characterized and their cytotoxic profile was evaluated on four melanoma cell lines (HT-144, SK-MEL-147, CHL-1, and WM1366). All complexes significantly reduced cell viability in a concentration-dependent manner. However, complex (2) bearing trans-4-(trifluoromethyl)cinnamic acid as the ligand was the most promising compound. We demonstrated that complex (2) inhibits cell cycle progression at the G1 phase and induces apoptosis in the CHL-1 cell line. Our data showed that cell cycle arrest at G1/S transition was, at least in part, due to reduction of ERK activation, CDKN1A (p21) upregulation and CCNE2 (cyclin E2) downregulation. Moreover, pro-apoptotic activity of complex (2) was ascribed to its ability to modulate BAX and Bcl-2 expression profiles leading to an increase in the BAX/Bcl-2 ratio. We also demonstrated that complex (2) affects the actin cytoskeleton organization pattern and inhibits the migration of CHL-1. Taken together, the data indicate the promising antitumor potential of complex (2) against melanoma cells and support further in vivo studies.
Lung cancer is the leading cause of cancer-related deaths globally, with nonsmall cell lung cancer (NSCLC) being the most prevalent type. Cisplatin and its derivatives are commonly used in classical chemotherapy, but their therapeutic efficacy is limited, and they came with significant side effects. The targeted therapies and immunotherapy have improved survival rates for certain groups of patients. However, overall survival for NSCLC remains very low, which contributes to the high mortality rate. Thus, the search for effective and affordable drugs is ongoing. In this context, ruthenium-based complexes have been extensively studied as promising anticancer agents. In our previous studies, three ruthenium(II) complexes containing cinnamic acid derivatives with ligands were synthesized and characterized. We demonstrated that the complex [Ru(trans-4-(trifluoromethyl)cinnam)(dppb)(bipy)]PF6 effectively inhibited the proliferation of melanoma cells with either an activating N-Ras mutation or a TP53 inactivation mutation. Therefore, in this study, we aimed to evaluate the antitumor potential of complex [Ru(3,4-cinnam)(dppb)(bipy)]PF6, named CINNAM, against nonsmall cell lung cancer cells A549 (TP53 wild type; K-Ras mutated) and H1299 (TP53 mutated; N-Ras mutated). CINNAM selectively targeted cancer cells over normal cells, with A549 cells showing higher sensitivity to the CINNAM compared to H1299 cells. CINNAM effectively reduced the proliferation of A549 cells by inducing cell cycle arrest at the G0/G1 phase. CINNAM modulated the expression profiles of key cell cycle regulators, CDKN1A, CCND1, and CCNE2. Further, we demonstrated that the cytotoxic activity of CINNAM is linked to its pro-oxidant and pro-apoptotic properties. The interactions of the complex with ct-DNA (calf thymus DNA) were analyzed, and based on the Kb value, the complex present intermediate affinity for DNA. In conclusion, CINNAM exhibits potent antiproliferative and pro-apoptotic effects on NSCLC cells, surpassing those observed with cisplatin.
The heterobimetallic 15-MC-5 metallacrown of formula [CeCu5(5mpzHA)5(NO3)(H2O)7]·2NO3·7H2O, designated MC-Ce, was synthesized using 5-methyl-2-pyrazinehydroxamic acid (5mpzHA) as a linker, reacting with CeIII and CuII salts under mild conditions. Single-crystal X-ray diffraction analysis reveals a crown-like [Cu5Ce(5mpzHA)5] core, characteristic of a 15-MC-5 system, with five CuII atoms at the rim of the crown and the CeIII ion occupying the dome of the crown, with water molecules, oxygen atoms and one nitrate anion filling the nine-coordination sphere around the CeIII ion, which exhibits a distorted spherical tricapped trigonal prism geometry. The thermogravimetric analysis evidences successive mass losses due to the removal of water molecules and decomposition of the structure after 217 °C, whereas the PXRD analysis of the thermal decomposition residue reveals the presence of copper and copper/cerium oxide particles. These nanocomposite materials were also synthesized using the metallacrown MC-Ce under a hydrothermal method in the presence of multi-walled carbon nanotubes (MWCNTs), affording insights that this metallacrown can act as a source precursor for the synthesis of these mixed cerium/copper oxide nanomaterials. The experimental χMT value in MC-Ce at room temperature is 3.175 cm3 mol−1 K, which is higher than the calculated one for one magnetically isolated CeIII plus five CuII ions, probably due to the antiferromagnetic interactions among CuII ions within the metallacrown hoop plus the thermal depopulation of JZ sublevels of CeIII ground state (5/2), which exhibit a small splitting under the anisotropic ligand field effects. The χMT decreases continuously until it reaches the value of 0.80 cm3 mol−1 K at 10 K, reinforcing the presence of intramolecular antiferromagnetic interactions.